Michael Singer
Director/Board Member at BIOPORTO A/S
Net worth: 15 M $ as of 2024-03-30
Profile
Michael S.
Singer founded HealthHonors in 2006, where he worked as Chief Scientific Officer from 2006 to 2009, Topokine Therapeutics, Inc. in 2012, where he worked as Secretary, Treasurer, Director& Vice President from 2012 to 2016, and Cartesian Therapeutics, Inc. (United States) in 2016, where he worked as Chairman & Chief Strategy Officer.
Dr. Singer also currently works at Bioporto A, as Independent Director from 2019, Pykus Therapeutics, Inc., as Director, Cartesian Therapeutics, Inc., as Director from 2023, Anodyne Nanotech, Inc., as Director, and Neutrolis, Inc., as Chief Medical Officer from 2019.
Dr. Singer also formerly worked at Boston Scientific Corp., as Medical Director, Novartis AG, as Director-Translational Medicine, and Novartis Institutes for Biomedical Research, Inc., as Director.
Dr. Singer received his undergraduate degree and doctorate degree from Yale University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
14.49% | 2024-04-07 | 23,473,393 ( 14.49% ) | 15 M $ | 2024-03-30 |
BIOPORTO A/S
0.06% | 2022-12-30 | 209,291 ( 0.06% ) | 39 713 $ | 2024-03-30 |
Michael Singer active positions
Companies | Position | Start |
---|---|---|
BIOPORTO A/S | Director/Board Member | 2019-08-14 |
Neutrolis, Inc.
Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Neutrolis, Inc. is a biotechnology company located in North Cambridge, MA. The company develops first-in-class therapies that target neutrophils and their pathogenic products, including nets. Neutrolis proprietary platform, Chromatinase™, is based on the naturally occurring enzymes that break down the extracellular chromatin that form nets. The company's lead product, NTR-441, is a patented, first-in-class, engineered DNASE1L3 analog with potential application in COVID-19, ARDS, lupus, rheumatoid arthritis, systemic sclerosis, and other net-mediated diseases. Neutrolis has received two competitive LabCentral Golden Ticket awards from Pfizer and Bristol-Myers Squibb. The company was founded by Abdul Hakkim and Toby Fox. Toby Fox has been the CEO since incorporation. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
Pykus Therapeutics, Inc.
Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Director/Board Member | - |
Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | Director/Board Member | - |
Former positions of Michael Singer
Companies | Position | End |
---|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Founder | 2023-11-12 |
Topokine Therapeutics, Inc.
Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Founder | 2015-12-31 |
HealthHonors
HealthHonors Miscellaneous Commercial ServicesCommercial Services HealthHonors provides behavioral economics consulting services. The company is based in Braintree, MA. The company was founded by Murat V. Kalayoglu, Michael S. Singer. HealthHonors was acquired by Tivity Health, Inc., part of Stonepoint Capital LLC from June 28, 2022 on October 14, 2009 for $14.70 million. | Founder | 2008-12-31 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Director/Board Member | - |
NOVARTIS AG | Corporate Officer/Principal | - |
Training of Michael Singer
Yale University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Distribution Services |
NOVARTIS AG | Health Technology |
BIOPORTO A/S | Health Technology |
Private companies | 7 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
HealthHonors
HealthHonors Miscellaneous Commercial ServicesCommercial Services HealthHonors provides behavioral economics consulting services. The company is based in Braintree, MA. The company was founded by Murat V. Kalayoglu, Michael S. Singer. HealthHonors was acquired by Tivity Health, Inc., part of Stonepoint Capital LLC from June 28, 2022 on October 14, 2009 for $14.70 million. | Commercial Services |
Topokine Therapeutics, Inc.
Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Health Technology |
Pykus Therapeutics, Inc.
Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Commercial Services |
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Commercial Services |
Neutrolis, Inc.
Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Neutrolis, Inc. is a biotechnology company located in North Cambridge, MA. The company develops first-in-class therapies that target neutrophils and their pathogenic products, including nets. Neutrolis proprietary platform, Chromatinase™, is based on the naturally occurring enzymes that break down the extracellular chromatin that form nets. The company's lead product, NTR-441, is a patented, first-in-class, engineered DNASE1L3 analog with potential application in COVID-19, ARDS, lupus, rheumatoid arthritis, systemic sclerosis, and other net-mediated diseases. Neutrolis has received two competitive LabCentral Golden Ticket awards from Pfizer and Bristol-Myers Squibb. The company was founded by Abdul Hakkim and Toby Fox. Toby Fox has been the CEO since incorporation. | Health Technology |
Anodyne Nanotech, Inc.
Anodyne Nanotech, Inc. BiotechnologyHealth Technology Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Michael Singer